Clinical trial · Observational
Comparison of Different Types of Surgery in Treating Patients With Early-stage Non-small Cell Lung Cancer
NCT02288026CI-TRIAL-00016031unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to compare early-stage peripheral non-small cell lung cancer lobectomy and sub-lobectomy surgery to evaluate if sub-lobectomy is as feasible and effective for the treatment of early-stage (diameter ≤2cm) peripheral non-small cell lung cancer as lobectomy.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Adenocarcinoma of the Lung | Lung Adenocarcinoma | ALIAS | 0.90 |
| Squamous Cell Lung Cancer | Lung Squamous Cell Carcinoma | ALIAS | 0.90 |
| Stage IA Non-small Cell Lung Cancer | Lung Non-Small Cell Carcinoma | CURATED_BROADER | 0.78 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- Arm I
- description
- Patients undergo lobectomy
- label
- Arm II
- description
- Patients undergo a wedge resection or anatomical segmentectomy
Primary outcomes (1)
- measure
- Disease-free survival
- timeFrame
- participants will be followed from surgical treatment at least 5 years unless any evidence of disease progression or death
Secondary outcomes (2)
- measure
- Overall survival
- timeFrame
- at least 5 years
- measure
- Pulmonary function
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 60 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. clinically diagnosed with stage I peripheral non-small cell lung cancer suitable for lobectomy. 2. T≤2cm，N0，M0. 3. aged 60 to 80 years old. 4. ECOG≤2. 5. according to the Ministry of Health, "with primary lung cancer diagnostic and treatment practices" (2011 edition) completed preoperative clinical staging examination. 6. voluntary participation, signed informed consent. Exclusion Criteria: 1. pathologic stage is N1, N2, or M1a. 2. received postoperative adjuvant therapy (chemotherapy or targeted therapy). 3. radiotherapy or chemotherapy before surgery. 4. small cell lung cancer 5. benign lesions 6. patient unwilling to cooperate with surgery or observation.
References
Publications (0)
Data not yet available
No reference posted for this study.